EssexBio

Essex-Bio Group

简繁 EN

ANNOUNCEMENTS & SHAREHOLDER INFORMATION

Normative Disclosure, Honest Communication

Date

Title

File

Times

2021-11-19

NEXT DAY DISCLOSURE RETURN

1395

2021-11-18

NEXT DAY DISCLOSURE RETURN

1353

2021-11-16

NEXT DAY DISCLOSURE RETURN

1356

2021-11-15

NEXT DAY DISCLOSURE RETURN

1396

2021-11-12

NEXT DAY DISCLOSURE RETURN

1421

2021-11-10

VOLUNTARY ANNOUNCEMENT FIRST PATIENT FIRST VISIT COMPLETED IN A PHASE 3 CLINICAL STUDY IN THE PRC IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS RELATING TO THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

1331

2021-11-08

NEXT DAY DISCLOSURE RETURN

1353

2021-11-05

NEXT DAY DISCLOSURE RETURN

1369

2021-11-03

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2021

1193

2021-11-02

NEXT DAY DISCLOSURE RETURN

1361

2021-11-01

NEXT DAY DISCLOSURE RETURN

1331

2021-10-29

NEXT DAY DISCLOSURE RETURN

1392

2021-10-28

NEXT DAY DISCLOSURE RETURN

1372

2021-10-27

NEXT DAY DISCLOSURE RETURN

1356

2021-10-26

NEXT DAY DISCLOSURE RETURN

1374

2021-10-25

NEXT DAY DISCLOSURE RETURN

1391

2021-10-22

NEXT DAY DISCLOSURE RETURN

1434

2021-10-21

NEXT DAY DISCLOSURE RETURN

1329

2021-10-18

NEXT DAY DISCLOSURE RETURN

1375

2021-10-15

NEXT DAY DISCLOSURE RETURN

1335

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT